LMOD2
Basic information
Region (hg38): 7:123655866-123664290
Links
Transcripts
Transcript IDs starting with ENST are treated as Ensembl, all others as RefSeq. Showing 3 of 3.
| Transcript ID | Protein ID | Coding exons | MANE Select | MANE Plus Clinical |
|---|---|---|---|---|
NM_207163.3 | NP_997046.1 | 3 | yes | - |
ENST00000458573.3 | ENSP00000411932.2 | 3 | yes | - |
ENST00000456238.2 | ENSP00000398975.2 | 2 | - | - |
Phenotypes
GenCC
Source:
- cardiomyopathy, dilated, 2G (Strong), mode of inheritance: AR
- dilated cardiomyopathy (Definitive), mode of inheritance: AR
- cardiomyopathy, dilated, 2G (Strong), mode of inheritance: AR
- cardiomyopathy, dilated, 2G (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Cardiomyopathy, dilated, 2G | AR | Cardiovascular | The condition involves severe and early-onset dilated cardiomyopathy (which can be lethal), but awareness can allow early medical and surgical management; Heart transplant has been described | Cardiovascular | 31517052; 34888509; 35188328; 35082396 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (84 variants)
- Cardiomyopathy,_dilated,_2G (8 variants)
- not_provided (2 variants)
- LMOD2-related_condition (2 variants)
- Familial_isolated_dilated_cardiomyopathy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LMOD2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_207163.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | ||||
| missense | 83 | 4 | 87 | |||
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 3 | 4 | |||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 4 | 3 | 83 | 4 | 1 |
Highest pathogenic variant AF is 0.000007663579
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| LMOD2 | protein_coding | protein_coding | ENST00000458573 | 3 | 8484 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 124630 | 0 | 20 | 124650 | 0.0000802 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.271 | 282 | 295 | 0.956 | 0.0000158 | 3584 |
| Missense in Polyphen | 117 | 122.5 | 0.95507 | 1448 | ||
| Synonymous | 0.117 | 115 | 117 | 0.986 | 0.00000695 | 1055 |
| Loss of Function | 2.00 | 8 | 16.8 | 0.475 | 8.77e-7 | 223 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000984 | 0.0000935 |
| Ashkenazi Jewish | 0.000103 | 0.0000994 |
| East Asian | 0.000226 | 0.000223 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000117 | 0.000115 |
| Middle Eastern | 0.000226 | 0.000223 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Mediates nucleation of actin filaments and thereby promotes actin polymerization (PubMed:18403713, PubMed:26370058, PubMed:25250574, PubMed:26417072). Plays a role in the regulation of actin filament length (By similarity). Required for normal sarcomere organization in the heart, and for normal heart function (PubMed:18403713). {ECO:0000250|UniProtKB:Q3UHZ5, ECO:0000269|PubMed:18403713, ECO:0000269|PubMed:25250574, ECO:0000269|PubMed:26370058, ECO:0000269|PubMed:26417072}.;
Intolerance Scores
- loftool
- 0.399
- rvis_EVS
- 0.15
- rvis_percentile_EVS
- 64.61
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0879
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- muscle contraction;actin filament polymerization;myofibril assembly;positive regulation of actin filament polymerization;actin nucleation;sarcomere organization;pointed-end actin filament capping
- Cellular component
- striated muscle thin filament;actin filament;myofibril;sarcomere;M band
- Molecular function
- actin binding;actin monomer binding;tropomyosin binding